Bioceltix S.A. has reached another milestone – approval for the production of a veterinary medicinal product for cell therapy – according to decision of the Main Pharmaceutical Inspectorate. Bioceltix, as one of the few companies in the world, received such consent, and it confirms that the direction of the Company’s development chosen by the Management Board was right.